<?xml version='1.0' encoding='utf-8'?>
<document id="24462784"><sentence text="A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats."><entity charOffset="77-92" id="DDI-PubMed.24462784.s1.e0" text="ginsenoside Rg1" /><entity charOffset="94-109" id="DDI-PubMed.24462784.s1.e1" text="ginsenoside Rb1" /><entity charOffset="114-125" id="DDI-PubMed.24462784.s1.e2" text="schizandrin" /><pair ddi="false" e1="DDI-PubMed.24462784.s1.e0" e2="DDI-PubMed.24462784.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24462784.s1.e0" e2="DDI-PubMed.24462784.s1.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s1.e0" e2="DDI-PubMed.24462784.s1.e2" /><pair ddi="false" e1="DDI-PubMed.24462784.s1.e1" e2="DDI-PubMed.24462784.s1.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s1.e1" e2="DDI-PubMed.24462784.s1.e2" /></sentence><sentence text="Ginsenoside Rg1, ginsenoside Rb1 and schizandrin are main bioactive components from Panax ginseng and Schisandra chinensis"><entity charOffset="0-15" id="DDI-PubMed.24462784.s2.e0" text="Ginsenoside Rg1" /><entity charOffset="17-32" id="DDI-PubMed.24462784.s2.e1" text="ginsenoside Rb1" /><entity charOffset="37-48" id="DDI-PubMed.24462784.s2.e2" text="schizandrin" /><pair ddi="false" e1="DDI-PubMed.24462784.s2.e0" e2="DDI-PubMed.24462784.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24462784.s2.e0" e2="DDI-PubMed.24462784.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s2.e0" e2="DDI-PubMed.24462784.s2.e2" /><pair ddi="false" e1="DDI-PubMed.24462784.s2.e1" e2="DDI-PubMed.24462784.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s2.e1" e2="DDI-PubMed.24462784.s2.e2" /></sentence><sentence text=" They have been found in many prescriptions of Traditional Chinese Medicines (TCM) and proven to be effective for prevention and treatment of cardiovascular disease" /><sentence text=" It is valuable to investigate their pharmacokinetic and pharmacodynamic behavior and potential synergistic effect for better drug development and clinical application" /><sentence text="" /><sentence text="Pharmacokinetic and nitric oxide (NO) release pharmacodynamic drug-drug interactions of ginsenoside Rg1, ginsenoside Rb1 and schisandrin were studied after intravenous administration of each compound with the dose of 10 mg/kg and their mixture with the total dose of 10 mg/kg to isoproterenol (ISO)-induced myocardial ischemia rats"><entity charOffset="20-32" id="DDI-PubMed.24462784.s6.e0" text="nitric oxide" /><entity charOffset="34-36" id="DDI-PubMed.24462784.s6.e1" text="NO" /><entity charOffset="88-103" id="DDI-PubMed.24462784.s6.e2" text="ginsenoside Rg1" /><entity charOffset="105-120" id="DDI-PubMed.24462784.s6.e3" text="ginsenoside Rb1" /><entity charOffset="125-136" id="DDI-PubMed.24462784.s6.e4" text="schisandrin" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e0" e2="DDI-PubMed.24462784.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e0" e2="DDI-PubMed.24462784.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e0" e2="DDI-PubMed.24462784.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e0" e2="DDI-PubMed.24462784.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e0" e2="DDI-PubMed.24462784.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e1" e2="DDI-PubMed.24462784.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e1" e2="DDI-PubMed.24462784.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e1" e2="DDI-PubMed.24462784.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e1" e2="DDI-PubMed.24462784.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e2" e2="DDI-PubMed.24462784.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e2" e2="DDI-PubMed.24462784.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e2" e2="DDI-PubMed.24462784.s6.e4" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e3" e2="DDI-PubMed.24462784.s6.e3" /><pair ddi="false" e1="DDI-PubMed.24462784.s6.e3" e2="DDI-PubMed.24462784.s6.e4" /></sentence><sentence text=" Drug concentrations in serum were determined using LC-MS method" /><sentence text=" Nitrite and nitrate (NOx(-)), the predominant oxidation product of NO in serum was used as an effective marker and quantitated by the method of high-performance liquid chromatography coupled with fluorescence detection (HPLC-FL)"><entity charOffset="1-8" id="DDI-PubMed.24462784.s8.e0" text="Nitrite" /><entity charOffset="13-20" id="DDI-PubMed.24462784.s8.e1" text="nitrate" /><entity charOffset="68-70" id="DDI-PubMed.24462784.s8.e2" text="NO" /><entity charOffset="22-23" id="DDI-PubMed.24462784.s8.e3" text="NO" /><pair ddi="false" e1="DDI-PubMed.24462784.s8.e0" e2="DDI-PubMed.24462784.s8.e0" /><pair ddi="false" e1="DDI-PubMed.24462784.s8.e0" e2="DDI-PubMed.24462784.s8.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s8.e0" e2="DDI-PubMed.24462784.s8.e3" /><pair ddi="false" e1="DDI-PubMed.24462784.s8.e0" e2="DDI-PubMed.24462784.s8.e2" /><pair ddi="false" e1="DDI-PubMed.24462784.s8.e1" e2="DDI-PubMed.24462784.s8.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s8.e1" e2="DDI-PubMed.24462784.s8.e3" /><pair ddi="false" e1="DDI-PubMed.24462784.s8.e1" e2="DDI-PubMed.24462784.s8.e2" /><pair ddi="false" e1="DDI-PubMed.24462784.s8.e3" e2="DDI-PubMed.24462784.s8.e3" /><pair ddi="false" e1="DDI-PubMed.24462784.s8.e3" e2="DDI-PubMed.24462784.s8.e2" /></sentence><sentence text=" The main pharmacokinetic parameters of T(1/2β), MRT(0-∞), Vd, Cl, and AUC, and the main pharmacodynamic parameters of Cmax, Tmax and AUEC were calculated by non-compartment model"><entity charOffset="63-65" id="DDI-PubMed.24462784.s9.e0" text="Cl" /></sentence><sentence text="" /><sentence text="The results indicated ginsenoside Rb1 and (or) schisandrin in mixture could significantly postpone the elimination of ginsenoside Rg1 in rat serum"><entity charOffset="22-37" id="DDI-PubMed.24462784.s11.e0" text="ginsenoside Rb1" /><entity charOffset="47-58" id="DDI-PubMed.24462784.s11.e1" text="schisandrin" /><entity charOffset="118-133" id="DDI-PubMed.24462784.s11.e2" text="ginsenoside Rg1" /><pair ddi="false" e1="DDI-PubMed.24462784.s11.e0" e2="DDI-PubMed.24462784.s11.e0" /><pair ddi="false" e1="DDI-PubMed.24462784.s11.e0" e2="DDI-PubMed.24462784.s11.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s11.e0" e2="DDI-PubMed.24462784.s11.e2" /><pair ddi="false" e1="DDI-PubMed.24462784.s11.e1" e2="DDI-PubMed.24462784.s11.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s11.e1" e2="DDI-PubMed.24462784.s11.e2" /></sentence><sentence text=" Co-administration of three compounds markedly increased the systemic exposure level of each compound in vivo" /><sentence text=" Ginsenoside Rg1 and ginsenoside Rb1 had the effect of inducing real-time NO release in rats concentration dependently"><entity charOffset="1-16" id="DDI-PubMed.24462784.s13.e0" text="Ginsenoside Rg1" /><entity charOffset="21-36" id="DDI-PubMed.24462784.s13.e1" text="ginsenoside Rb1" /><entity charOffset="74-76" id="DDI-PubMed.24462784.s13.e2" text="NO" /><pair ddi="false" e1="DDI-PubMed.24462784.s13.e0" e2="DDI-PubMed.24462784.s13.e0" /><pair ddi="false" e1="DDI-PubMed.24462784.s13.e0" e2="DDI-PubMed.24462784.s13.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s13.e0" e2="DDI-PubMed.24462784.s13.e2" /><pair ddi="false" e1="DDI-PubMed.24462784.s13.e1" e2="DDI-PubMed.24462784.s13.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s13.e1" e2="DDI-PubMed.24462784.s13.e2" /></sentence><sentence text=" Schisandrin had no effect of inducing real-time NO release in this study"><entity charOffset="1-12" id="DDI-PubMed.24462784.s14.e0" text="Schisandrin" /><entity charOffset="49-51" id="DDI-PubMed.24462784.s14.e1" text="NO" /><pair ddi="false" e1="DDI-PubMed.24462784.s14.e0" e2="DDI-PubMed.24462784.s14.e0" /><pair ddi="false" e1="DDI-PubMed.24462784.s14.e0" e2="DDI-PubMed.24462784.s14.e1" /></sentence><sentence text=" The mixture of ginsenoside Rg1, Rb1 and schisandrin administration exhibited synergistic effect of inducing NO release in ISO treated rats"><entity charOffset="16-31" id="DDI-PubMed.24462784.s15.e0" text="ginsenoside Rg1" /><entity charOffset="41-52" id="DDI-PubMed.24462784.s15.e1" text="schisandrin" /><entity charOffset="109-111" id="DDI-PubMed.24462784.s15.e2" text="NO" /><pair ddi="false" e1="DDI-PubMed.24462784.s15.e0" e2="DDI-PubMed.24462784.s15.e0" /><pair ddi="false" e1="DDI-PubMed.24462784.s15.e0" e2="DDI-PubMed.24462784.s15.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s15.e0" e2="DDI-PubMed.24462784.s15.e2" /><pair ddi="false" e1="DDI-PubMed.24462784.s15.e1" e2="DDI-PubMed.24462784.s15.e1" /><pair ddi="false" e1="DDI-PubMed.24462784.s15.e1" e2="DDI-PubMed.24462784.s15.e2" /></sentence><sentence text="" /><sentence text="The result obtained from this study suggested pharmacokinetic and pharmacodynamic drug-drug interactions between ginsenoside Rg1, Rb1 and schisandrin"><entity charOffset="113-128" id="DDI-PubMed.24462784.s17.e0" text="ginsenoside Rg1" /><entity charOffset="138-149" id="DDI-PubMed.24462784.s17.e1" text="schisandrin" /><pair ddi="false" e1="DDI-PubMed.24462784.s17.e0" e2="DDI-PubMed.24462784.s17.e0" /><pair ddi="false" e1="DDI-PubMed.24462784.s17.e0" e2="DDI-PubMed.24462784.s17.e1" /></sentence><sentence text=" The study provided valuable information for drug development and clinical application of TCM" /><sentence text="" /></document>